Le Lézard
Classified in: Covid-19 virus
Subjects: Conference, Event, Webcast

PTCE Announces That 10th Anniversary of Directions in Pharmacy® Is Now a Virtual Conference


PTCE, a leader in continuing education for retail, health-system, oncology, managed care and specialty pharmacists, announces that the 10th annual Directions in Pharmacy® continuing education (CE) spring conference series will be transitioning to a virtual format for three of its four events to ensure safety amid the new coronavirus global pandemic.

"Pharmacists are vital to our healthcare system. Educating our attendees in a safe environment is essential," said Jim Palatine, RPh, MBA, president of PTCE. "That is why we have made the decision to transition the first three meetings in the Directions in Pharmacy® continuing education spring conference series to live virtual CE-accredited webcasts, where attendees can learn and earn CE credits from the comfort and shelter of their own homes."

The meetings scheduled for April 4, April 25 and May 16 are transitioning into live broadcasts. The CE-accredited broadcasts will follow a similar agenda via live video stream and be offered on a proprietary broadcasting platform.

Directions in Pharmacy® is a full-day regional conference for community and health-system pharmacists. It offers them the opportunity to participate in interactive sessions that provide the most current and relevant information to implement in their practices. Sessions focus on disease-state management, clinical data and treatment guidelines, as well as best practices for optimal care for patients in a wide variety of therapeutic areas. Expert faculty speakers will address topics including treatment and management of diabetes, biosimilars, cardiovascular disease, immuno-oncology, infectious diseases and immunization recommendations.

Accredited by the Accreditation Council for Pharmacy Education, each meeting provides attendees with the opportunity to earn up to 6.0 CE credits, including law, patient safety and immunization credit.

For more information and to register for a virtual conference, click here.

About Pharmacy Times Continuing Educationtm

Pharmacy Times Continuing Educationtm (PTCE) is a leader in continuing education for retail, health system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). PTCE's print, online and live CPE activities are designed to improve the knowledge, competence and skills of pharmacists to better prepare them to provide the highest quality of pharmacy care to the patients they serve and the physicians they assist as part of a multidisciplinary treatment and management team. PTCE is a brand of MJH Life Sciencestm, the largest privately held, independent, full-service medical media company in North America. dedicated to delivering trusted health care news across multiple channels.


These press releases may also interest you

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Nebula Energy and Gogoro Inc , a global technology leader in battery-swapping ecosystems that enable sustainable mobility solutions for cities,...

25 avr 2024
Ankur Daga, CEO of Angara, a leading online DTC fine jewelry retail brand, has been named the winner of a Gold Stevie® Award in the Best Entrepreneur - Retail category in the 22nd Annual American Business Awards®. Ankur Daga Wins Gold...

25 avr 2024
The report titled "Identity Governance & Administration Market by Component (Services, Solution), Modules (Access Certification & Compliance Control, Access Management, Identity Lifecycle Management), Organization Size, Deployment, Vertical - Global...

25 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

25 avr 2024
Results  For the year ended January 31, 2024, the Company's revenues decreased by $139,027,000 to $578,945,000 compared to $717,972,000 recorded for the year ended January 31, 2023, a decrease of 19.4%. This decrease is mainly explained by the...



News published on and distributed by: